We are live on
!
Find out more
SR
Summer Road Portfolio holdings
AUM
$142M
1-Year Est. Return
43.61%
This Fund
S&P 500
This Quarter
Est. Return
-30.3%
1 Year Est. Return
+43.61%
3 Year Est. Return
+101.14%
5 Year Est. Return
-35.41%
10 Year Est. Return
+349.33%
AUM
$40.2M
AUM Growth
-$16M
(-28%)
Cap. Flow
+$1.13M
Cap. Flow
% of AUM
2.82%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
1
New
–
Increased
1
Reduced
–
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Ocular Therapeutix
OCUL
|
+$1.13M |
Top Sells
No sells this quarter
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Ocular Therapeutix
OCUL
$1.96B
| $40.2M | 100% |
5,764,761
+145,900
| +3% | +$1.13M |
|
Similar funds
EC
TA
AC
ACP
PC
YEPX
ALM
BRIA
Summer Road's Q4 2021 Portfolio in Review
As of Q4 2021, Summer Road held 1 position worth $40.2M, down 28% from $56.2M the previous quarter. Its ten largest holdings account for 100% of the portfolio.
Trading was light in Q4 2021: portfolio turnover was 0%. Summer Road opened no new positions and made no exits, leaving the 1-position portfolio largely intact.
By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.
- Summer Road added most to Ocular Therapeutix in Q4 2021, an estimated $1.13M increase.
- Summer Road's ten largest holdings make up 100% of its $40.2M portfolio in Q4 2021.
- Summer Road opened 0 new positions and closed 0 in Q4 2021.
- Summer Road's portfolio value fell 28% quarter-over-quarter to $40.2M.
Based on Summer Road's 13F filing for Q4 2021, filed 14 Feb 2022.